These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1347002)

  • 1. Felbamate metabolism in pediatric and adult beagle dogs.
    Yang JT; Morris M; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1992; 20(1):84-8. PubMed ID: 1347002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Felbamate metabolism in the rat, rabbit, and dog.
    Yang JT; Adusumalli VE; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1991; 19(6):1126-34. PubMed ID: 1687020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Felbamate pharmacokinetics in the rat, rabbit, and dog.
    Adusumalli VE; Yang JT; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1991; 19(6):1116-25. PubMed ID: 1687019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of felbamate in pediatric and adult beagle dogs.
    Adusumalli VE; Gilchrist JR; Wichmann JK; Kucharczyk N; Sofia RD
    Epilepsia; 1992; 33(5):955-60. PubMed ID: 1396441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
    Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH
    Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of felbamate and three metabolites in rat and dog plasmas by high-performance liquid chromatography.
    Romanyshyn LA; Wichmann JK; Kucharczyk N; Sofia RD
    J Chromatogr; 1993 Dec; 622(2):229-34. PubMed ID: 8150870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interaction studies between felbamate and vigabatrin.
    Reidenberg P; Glue P; Banfield C; Colucci R; Meehan J; Rey E; Radwanski E; Nomeir A; Lim J; Lin C
    Br J Clin Pharmacol; 1995 Aug; 40(2):157-60. PubMed ID: 8562299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthesis, in vitro reactivity, and evidence for formation in humans of 5-phenyl-1,3-oxazinane-2,4-dione, a metabolite of felbamate.
    Thompson CD; Miller TA; Barthen MT; Dieckhaus CM; Sofia RD; Macdonald TL
    Drug Metab Dispos; 2000 Apr; 28(4):434-9. PubMed ID: 10725312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose pharmacokinetics of felbamate in patients with renal dysfunction.
    Glue P; Sulowicz W; Colucci R; Banfield C; Pai S; Lin C; Affrime MB
    Br J Clin Pharmacol; 1997 Jul; 44(1):91-3. PubMed ID: 9241102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
    Adusumalli VE; Choi YM; Romanyshyn LA; Sparadoski RE; Wichmann JK; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1993; 21(4):710-6. PubMed ID: 8104132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidation.
    Hooper WD; Franklin ME; Glue P; Banfield CR; Radwanski E; McLaughlin DB; McIntyre ME; Dickinson RG; Eadie MJ
    Epilepsia; 1996 Jan; 37(1):91-7. PubMed ID: 8603632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of felbamate, a novel antiepileptic drug: application of mixed-effect modeling to clinical trials.
    Graves NM; Ludden TM; Holmes GB; Fuerst RH; Leppik IE
    Pharmacotherapy; 1989; 9(6):372-6. PubMed ID: 2694113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification in patient urine samples of felbamate and three metabolites: acid carbamate and two mercapturic acids.
    Thompson CD; Barthen MT; Hopper DW; Miller TA; Quigg M; Hudspeth C; Montouris G; Marsh L; Perhach JL; Sofia RD; Macdonald TL
    Epilepsia; 1999 Jun; 40(6):769-76. PubMed ID: 10368077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition, metabolism, and excretion of the anticancer agent crisnatol in the rat.
    Patel DK; Woolley JL; Shcokcor JP; Johnson RL; Taylor LC; Sigel CW
    Drug Metab Dispos; 1991; 19(2):491-7. PubMed ID: 1676660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of felbamate on the pharmacokinetics of phenobarbital.
    Reidenberg P; Glue P; Banfield CR; Colucci RD; Meehan JW; Radwanski E; Mojavarian P; Lin CC; Nezamis J; Guillaume M
    Clin Pharmacol Ther; 1995 Sep; 58(3):279-87. PubMed ID: 7554701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Felbamate in vitro metabolism by rat liver microsomes.
    Adusumalli VE; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1991; 19(6):1135-8. PubMed ID: 1687021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentially reactive cyclic carbamate metabolite of the antiepileptic drug felbamate produced by human liver tissue in vitro.
    Kapetanovic IM; Torchin CD; Thompson CD; Miller TA; McNeilly PJ; Macdonald TL; Kupferberg HJ; Perhach JL; Sofia RD; Strong JM
    Drug Metab Dispos; 1998 Nov; 26(11):1089-95. PubMed ID: 9806951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of felbamate and three metabolites in human plasma by high-performance liquid chromatography.
    Romanyshyn LA; Wichmann JK; Kucharczyk N; Sofia RD
    Ther Drug Monit; 1994 Feb; 16(1):83-9. PubMed ID: 8160261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition and metabolism of finasteride in dogs.
    Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
    Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.